Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITF2357 Phase IIA in JAK2V617F+ MPN
NCT00606307Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Dec 2007
- Primary completion
- Dec 2008
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of givinostat in polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF), sponsored by Italfarmaco. Started Dec 2007; status: completed.
02
Drugs
givinostat
03
Conditions
polycythemia vera (PV)essential thrombocythemia (ET)myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00606307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00606307.